FDA Guidance Emphasizes Patient Engagement in Rare Disease Drug Development
The FDA recently released updated guidance, titled “Rare Diseases: Considerations for the Development of Drugs…
Browsing: Multimedia
NEW White Paper on Alternative Funding Programs
In recent years, the adoption of alternative funding programs (AFPs) among self-funded employer-sponsored plans has…
Study Finds 340B Hospitals Significantly Markup Infusion Drugs
A recent study published in the New England Journal of Medicine examined the pricing practices…
Senators Seek Input on Draft 340B Reform Bill
The Senate 340B Working Group is soliciting additional stakeholder input on key longstanding issues surrounding…
MDPC’s New Policy Paper on Parkinson’s Disease Care Access
This month, the Movement Disorder Policy Coalition (MDPC) released a new policy paper, “Parkinson’s Disease:…
Aimed Alliance Releases 2023 Annual Impact Report
In 2023, Aimed Alliance engaged in a wide variety of activities to protect and enhance…
Senate Pushes for FTC Progress in PBM Investigation
Senate Commerce Committee leaders, Maria Cantwell and Chuck Grassley, along with 12 lawmakers, are requesting…
“Plan E”: A Proposal for a Universal Benefit for Cell and Gene Therapies
Cell and gene therapies (CGTs) have provided new optimism for patients living with diseases previously…
Canadians Express Concerns Regarding Florida’s Importation Program
Florida’s plan to import prescription drugs from Canada is facing a potential setback as Canadian…
CMS Finalizes Electronic Prior Authorization Rule
On January 17, 2024, the Centers for Medicare & Medicaid Services (CMS) finalized the CMS…